NCT02981940 2025-09-02A Study of Abemaciclib in Recurrent GlioblastomaDana-Farber Cancer InstitutePhase 2 Active not recruiting45 enrolled 10 charts
NCT00238303 2014-05-23Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeNational Cancer Institute (NCI)Phase 2 Completed103 enrolled 10 charts